AUG 05, 2016 9:27 AM PDT

Holmes Unveiled New 'Minilab' Device to Dubious Crowd

WRITTEN BY: Xuan Pham
Theranos CEO Elizabeth Holmes recently took the company to a place it’s never been before: to one of the most popular science conferences in the world. This coming-out appearance came on the heels of a string of regulatory turmoil that ended with Holmes being banned from owning or running any clinical laboratories for two years. Was Holmes making amends with the scientific community? Many are still unconvinced.

When Holmes stepped out on the stage of the American Association of Clinical Chemistry conference, she was greeted with a packed audience. Though some people resented that Holmes was given a much coveted public platform amidst a tremenous cloud of suspicion surrounding Theranos’ credibility, all were eager to hear what she had to say.

But those who were expecting a big reveal on the science behind Theranos’ droplet technology were sorely disappointed. “We know there are a lot of questions about the past, and we will address those in the appropriate forum,” Holmes said. Instead, Holmes spoke on the “latest version” of a new invention by Theranos.

Keeping with the theme of “smaller is better,” the new unveiled technology is an automated minilab that can carry out a variety of different tests with a small amount of blood sample. Officially named the Theranos Virtual Analyzer and Theranos Sample Processing Unit, the device is the size of a placemat and was purported to function in many locations, including remote areas with limited clinical capacity.

Doing a complete 180-degree, Holmes actually presented data showing how Theranos’ miniLab fared in comparison to another testing device.
Image: AACC/Theranos

But if this is Holmes’ way to make amends with the scientific community, she is off to a rough start. At the end of the 90-minute presentation, questions arose regarding the credibility of this new device given the outcome of the last revolutionary technology by Theranos. Furthermore, both devices seem to rest upon the same unproven concept of quality lab results with a small amount of sample.
 

Indeed, Stephen Master, a professor of Weill Cornell Medical College and a moderator on the panel for Holmes’ presentation asked what was on many peoples’ minds: "These claims that you have made that were very broad early on, [but] the evidence you've presented fall short of that. So how should we think about that?"

In response, Holmes said: “We chose this meeting to begin engaging in a scientific exchange. We wanted to introduce the invention.” She also added, “I wish I had started earlier."

Scientists are skeptical by nature, but Holmes has invited even more skepticism based her unwillingness to share the scientific evidence to back up Theranos’ claims. Since its founding days, the company has yet to release any details of their testing equipment or methodology. And they’ve not published any data in peer-reviewed scientific literature. In short, Theranos’ claims has never be verified by the scientific community.

Nevertheless, opening Theranos to scientific scrutiny is a step in the right direction, though Holmes will probably have to travel far to earn back any credibility.

Additional sources: CNN, Business Insider, MIT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 13, 2019
Health & Medicine
AUG 13, 2019
Blood-Brain Barrier Impairment and Its Role in Alzheimer's Disease
In healthy people, the blood-brain barrier (BBB), which is fromed by brain endothelial cells, strictly controls the entrance of harmful materials into...
SEP 13, 2019
Clinical & Molecular DX
SEP 13, 2019
Apple Watch New Research App: A Boon to Women's Health
The Apple company, in 2018, enrolled more than 400,000 people in its Apple Heart Study conducted in partnership with Stanford University researchers....
SEP 18, 2019
Health & Medicine
SEP 18, 2019
Honey As An Antibacterial Against Methicillin-Resistant Staphylococcus Aureus
Honey has been used for its medicinal properties for thousands of years to treat wound infections, gastrointestinal ailments, and burns. Because of th...
NOV 05, 2019
Cannabis Sciences
NOV 05, 2019
Single Exposure to CBD & THC Disrupts Embryonic Development
It only takes one incidence of cannabinoid exposure during the first month of pregnancy to yield detrimental effects on a developing embryo. New research r...
NOV 25, 2019
Clinical & Molecular DX
NOV 25, 2019
eRapid: molecular diagnostic power in the palm of your hand
We've heard lofty biotech promises in the news of being able to diagnose diseases from a single drop of blood. Yet, diagnostic procedures for the maj...
DEC 18, 2019
Clinical & Molecular DX
DEC 18, 2019
Germs don't stand a chance with new AI-powered diagnostic platform
We are steadily losing our edge in the war against infectious bacteria. A huge surge in antibiotic resistance is threatening healthcare and agricultural in...
Loading Comments...